Introducing advanced MRI to individualize radiotherapy planning of patients with glioblastoma

Patients diagnosed with glioblastoma face poor prognosis, as the median survival from initial diagnosis is less than 15 months. Radiotherapy is considered to be one of the fundamentals of glioblastoma therapy and is given after maximum safe tumour resection or biopsy. Delineation of the gross tumour volume (GTV) and the clinical target volume ...